Disability News and Research

RSS

Insilico Medicine collaborates with MAWI to develop multi-modal biomarkers of aging

Cardiovascular disease is the leading cause of death and disability in the world. On the eve of the annual World Heart Day, September 29th, Insilico Medicine, Inc., a Rockville-based next-generation artificial intelligence company specializing in the application of deep learning for target identification, drug discovery and aging research announced a research collaboration agreement with MAWI, the next-generation consumer and clinical wearable company, the developer of one of the most accurate clinical-grade ECG wearable devices.

28 Sep 2018

Taken for a ride: After ATV crash, doctor gets $56,603 bill for air ambulance trip

It was the first — and only — time Dr. Naveed Khan, a 35-year-old radiologist, ever rode in an all-terrain vehicle.

28 Sep 2018

Study reveals how a person's social network affects neurological outcomes

Are healthy and unhealthy habits contagious? Can a person's social network influence their risk of disease? It's a contentious idea but one that researchers want to explore in the future and better understand.

27 Sep 2018

Machine learning may be useful tool to predict outcomes for people at risk of psychosis, depression

Machine learning, also known as artificial intelligence, could be a useful tool for predicting how well people at high risk of psychosis or with recent onset depression will function socially in the future, an international research study has found.

26 Sep 2018

5 things to know about Trump’s new ‘public charge’ immigration proposal

A proposed rule from the White House would make it harder for legal immigrants to get green cards if they have received certain kinds of public assistance — including Medicaid, food stamps and housing subsidies. Green cards allow them to live and work permanently in the United States.

25 Sep 2018

DFG establishes nine new Research Units

The Deutsche Forschungsgemeinschaft is establishing nine new Research Units, following a decision by the Senate and the Joint Committee in Bonn.

25 Sep 2018

‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms

Alcohol is a leading contributor to death and disability worldwide, but governments haven’t responded to the issue with the attention, resources and action this urgent issue requires, says “Trouble Brewing,” a new report from global health and development organizations, Vital Strategies, the NCD Alliance, IOGT International and the Global Alcohol Policy Alliance.

25 Sep 2018

Researchers find impact of neurobehavioral symptoms on employment in adults with TBI

Kessler Foundation researchers have published their findings linking behavioral symptoms with employment outcomes among adults with moderate to severe traumatic brain injury.

24 Sep 2018

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it has acquired the license for LUM-201, an investigational orally administered small molecule that promotes secretion of growth hormone from the pituitary gland, from Ammonett Pharma LLC.

24 Sep 2018

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 PREVENT study of Soliris in patients with anti-aquaporin-4 auto antibody-positive neuromyelitis optica spectrum disorder.

24 Sep 2018

MS Society: Link between smoking and multiple sclerosis is 'clearer than ever'

The link between smoking and multiple sclerosis (MS) is “clearer than ever”, the MS Society has announced. Not only are people who smoke more likely to develop MS, smoking can also speed up how fast people with MS become disabled.

24 Sep 2018

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended approval of Gilenya (fingolimod) for the treatment of children and adolescents 10 to 17 years of age with relapsing remitting forms of multiple sclerosis.

24 Sep 2018

Research scientist at Kessler Foundation receives $10,000 grant to study aphasia after stroke

Olga Boukrina, PhD, research scientist in Stroke Rehabilitation Research at Kessler Foundation, has received a $10,000 grant from the Mabel H. Flory Charitable Trust.

21 Sep 2018

Scientists find wild African monkeys infected with bacterium that causes syphilis, yaws in humans

An international research team, led by scientists from the German Primate Center, the Robert Koch Institute, the Max Planck Institute for Evolutionary Anthropology, McGill University, Masaryk University, the University of Tübingen and the Max Planck Institute for the Science of Human History, has successfully recovered genomes of the bacterium Treponema pallidum, which causes syphilis and yaws in humans, from wild nonhuman primate populations across sub-Saharan Africa.

20 Sep 2018

Mediterranean-style diet appears to reduce stroke risk in women

One of the largest and longest-running efforts to evaluate the potential benefits of the Mediterranean-style diet in lowering risk of stroke found that the diet may be especially protective in women over 40 regardless of menopausal status or hormone replacement therapy, according to new research in the American Heart Association's journal Stroke.

20 Sep 2018

New guidance for treatment of bone loss in hematologic stem cell transplant Recipients

Hematopoietic stem cell transplantation is the treatment of choice for many patients with malignant and non-malignant hematological diseases, such as leukemia and multiple myeloma. The success of recent advances in such transplantation techniques and supportive care measures, has led to greater numbers of long-term HSCT survivors.

20 Sep 2018

Older individuals with multiple sclerosis report higher quality of life than younger counterparts

A recent brief report by MS researchers provides preliminary evidence that older individuals with multiple sclerosis report lower levels of depression and higher quality of life than their younger counterparts.

20 Sep 2018

Processing speed important to higher order cognitive function in multiple sclerosis patients

A recent article by Kessler Foundation researchers underscores the importance of processing speed in overall cognitive function in individuals with multiple sclerosis and their performance of everyday life activities.

19 Sep 2018

Penn researchers find common thread linking almost all TNR expansion diseases

In a class of roughly 30 neurological disorders that includes ALS, Huntington's Disease and Fragile X Syndrome, the relevant mutant gene features sections of repeating base pair sequences known as short tandem repeats, or STRs. Healthy people have STRs of normal lengths distributed across their DNA.

19 Sep 2018

UCalgary study could help physicians make better treatment decisions for stroke

More than 80 percent of strokes are caused when a blood vessel to the brain becomes blocked, called an ischemic stroke.

19 Sep 2018

Disability News and Research

Insilico Medicine collaborates with MAWI to develop multi-modal biomarkers of aging

Taken for a ride: After ATV crash, doctor gets $56,603 bill for air ambulance trip

Study reveals how a person's social network affects neurological outcomes

Machine learning may be useful tool to predict outcomes for people at risk of psychosis, depression

5 things to know about Trump’s new ‘public charge’ immigration proposal

DFG establishes nine new Research Units

‘Trouble Brewing’ report highlights steps that governments can take to reduce alcohol-related harms

Researchers find impact of neurobehavioral symptoms on employment in adults with TBI

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

MS Society: Link between smoking and multiple sclerosis is 'clearer than ever'

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

Research scientist at Kessler Foundation receives $10,000 grant to study aphasia after stroke

Scientists find wild African monkeys infected with bacterium that causes syphilis, yaws in humans

Mediterranean-style diet appears to reduce stroke risk in women

New guidance for treatment of bone loss in hematologic stem cell transplant Recipients

Older individuals with multiple sclerosis report higher quality of life than younger counterparts

Processing speed important to higher order cognitive function in multiple sclerosis patients

Penn researchers find common thread linking almost all TNR expansion diseases

UCalgary study could help physicians make better treatment decisions for stroke

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

Latest News